Who has invested in Avenzo Therapeutics?

OrbiMed, Foresite Capital, SR One, Lilly Asia Ventures, New Enterprise Associates (NEA), Deep Track Capital are named among the investors backing Avenzo Therapeutics.

Avenzo Therapeutics Funding: $446M Raised, Series A (2024)

Avenzo Therapeutics funding overview

Avenzo Therapeutics is a Biotech company based in San Diego, California. Avenzo Therapeutics has raised $446M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in November 2024. The round record for Avenzo Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include OrbiMed, Foresite Capital, SR One, Lilly Asia Ventures, New Enterprise Associates (NEA), Deep Track Capital and 3 others. 9 distinct backers are named across the disclosed rounds.

Avenzo Therapeutics at a glance

Total raised: $446M
Latest round: Series A
Latest round date: November 2024
Industry: Biotech
Headquarters: San Diego, California
Notable investors: OrbiMed, Foresite Capital, SR One, Lilly Asia Ventures, New Enterprise Associates (NEA), Deep Track Capital, Sofinnova Investments, Sands Capital

Frequently asked about Avenzo Therapeutics funding

How much has Avenzo Therapeutics raised?: Avenzo Therapeutics has raised $446M in total disclosed funding across the rounds on record.
Who has invested in Avenzo Therapeutics?: OrbiMed, Foresite Capital, SR One, Lilly Asia Ventures, New Enterprise Associates (NEA), Deep Track Capital are named among the investors backing Avenzo Therapeutics.
What was the latest Avenzo Therapeutics funding round?: The most recent disclosed round is a Series A, announced in November 2024.
Where is Avenzo Therapeutics based?: Avenzo Therapeutics is based in San Diego, California.
What sector does Avenzo Therapeutics operate in?: Avenzo Therapeutics is tracked under Biotech from San Diego, California, with $446M in disclosed funding.
When did Avenzo Therapeutics last raise?: The last disclosed Avenzo Therapeutics round closed in November 2024 at Series A.

Totals shown for Avenzo Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in San Diego and the investors behind them below.

Avenzo Therapeutics Funding: $446M Raised, Series A (2024)

Avenzo Therapeutics funding overview

Avenzo Therapeutics at a glance

Frequently asked about Avenzo Therapeutics funding

Companies related to Avenzo Therapeutics (40)

Browse related funding lists (10)